Consensus Report

HRT & Menopause

3.8

Strong Consensus

out of 5

Based on 18 videos (34 hours analyzed) across the experts · Updated 2026-06-24

Stance update (Nov 2025): The U.S. FDA moved to remove the boxed ("black box") warning on menopausal hormone therapy — the warnings for cardiovascular disease, breast cancer, and probable dementia — essentially the regulatory catch-up to the WHI reframe the experts below have argued for years. The endometrial-cancer warning for systemic estrogen-only therapy (in women with a uterus) stays, and label rewrites are rolling out over roughly six months, with new guidance noting benefits when therapy starts within ~10 years of menopause onset.

Expert Positions

Andrew Huberman
Andrew Huberman
Platforms the Modern Reframe (Haver, Gottfried)
Peter Attia
Peter Attia
Champions HRT; Calls the WHI Fear 'Overblown'
Rhonda Patrick
Rhonda Patrick
No Direct Coverage
Bryan Johnson
Bryan Johnson
No Direct Coverage
Mark Hyman
Mark Hyman
Supports HRT — Lifestyle-First & Bioidentical

The Verdict

Among the experts who actually cover it, the agreement is unanimous and one-directional: hormone therapy (HRT/MHT) is a reasonable, often beneficial medical option for many women near menopause onset, and the post-WHI blanket fear was a major overcorrection. Three of the five experts engage it substantively (Attia strongly, Huberman and Hyman supportively); Rhonda Patrick and Bryan Johnson have no direct coverage. This is a decision to make with a menopause-trained clinician — not a self-prescribed protocol.

Where They Disagree

Lifestyle-first vs. hormones-forward: Hyman gates HRT behind functional-medicine foundations (blood sugar, fiber, stress, xenoestrogen reduction) and treats it as the next step if lifestyle is insufficient; Attia (and his guest Rachel Rubin) treat HRT as a primary intervention that should be proactively offered, not a last resort.

Solo conviction vs. host framing: Attia makes emphatic first-person claims ('the fears are completely overblown'); Huberman conveys the same conclusion largely through expert guests and is noticeably more cautious in his own solo voice, flagging estrogen-dependent-cancer concerns.

+ 2 more disagreements in the full report

About This Analysis

This consensus report on HRT & Menopause is based on 18 videos (34 hours analyzed) from five longevity experts: Andrew Huberman, Peter Attia, Rhonda Patrick, Bryan Johnson, and Mark Hyman. Each expert's position was independently analyzed from their published video content, including lectures, podcast episodes, and Q&A sessions with 1,000+ guest scientists.

The full report includes 9 key findings, dosage and protocol details, expert deep dives with direct video citations and timestamps, risk considerations, and related supplement synergies.

Frequently Asked Questions

What do experts agree on about hrt & menopause?

Among the experts who actually cover it, the agreement is unanimous and one-directional: hormone therapy (HRT/MHT) is a reasonable, often beneficial medical option for many women near menopause onset, and the post-WHI blanket fear was a major overcorrection. Three of the five experts engage it substantively (Attia strongly, Huberman and Hyman supportively); Rhonda Patrick and Bryan Johnson have no direct coverage.

Where do the experts disagree on hrt & menopause?

Lifestyle-first vs. hormones-forward: Hyman gates HRT behind functional-medicine foundations (blood sugar, fiber, stress, xenoestrogen reduction) and treats it as the next step if lifestyle is insufficient; Attia (and his guest Rachel Rubin) treat HRT as a primary intervention that should be proactively offered, not a last resort. Solo conviction vs. host framing: Attia makes emphatic first-person claims ('the fears are completely overblown'); Huberman conveys the same conclusion largely through expert guests and is noticeably more cautious in his own solo voice, flagging estrogen-dependent-cancer concerns. How hard to relax the timing window: most framing endorses starting near onset, but Attia's guest Rachel Rubin argues recent data challenges strict age cutoffs and that women should be offered therapy more broadly, while Attia himself flags long-term continuation well beyond the window as the biggest remaining unknown.

How strong is the expert consensus on hrt & menopause?

The consensus on hrt & menopause scores 3.8/5 — a strong level of agreement across Huberman, Attia, Patrick, Johnson, and Hyman, based on their public videos.

Common Questions

Related Reports

Unlock the Full Report

Get dosages, timing protocols, expert deep dives with video citations, and risks for HRT & Menopause.

Every recommendation traces back to a specific expert, video, and timestamp.

$9/month or $79/year · Cancel anytime